Abstract
Pharmacokinetic data plays an important role in the evaluation of new drugs. They help to extrapolate data of in vitro to those of in vivo, to correlate data of non-clinical pharmacological experiments with those of clinical trials, and also to predict the possibility of drug interaction. The role of pharmacokinetic data in the process of review of pharmacological data in NDA was explained. The purpose of the on-going study to revise Japanese Guidelines for Non-clinical Pharmacokinetic Studies and the discussions in the working group were also introduced.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
